Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning (SalbutamolOP)
Organophosphate Poisoning
About this trial
This is an interventional treatment trial for Organophosphate Poisoning focused on measuring Organophosphate, insectiside, Salbutamol, Atropine
Eligibility Criteria
Inclusion Criteria:
- age 12 yrs or older
- clinical features of OP poisoning
- requiring oxygen and atropine and give consent
Exclusion Criteria:
- age 11 yrs or younger
- no requirement for atropine
Sites / Locations
- Sylhet M.A.G.Osmani Medical College Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Experimental
Experimental
'Standard care'
'Standard care+ 2.5 mg Salbutamol'
'Standard care+ 5 mg Salbutamol'
Standard care= Intravenous fluids, Oxygen by face mask, Intubation if necessary, Mechanical ventilation (Engstrom Pro by GE) if necessary, Cardiac monitor (Infunix IP4050), Atropine (anti-muscarinic drug; G-Atropine) by intravenous route, Pralidoxime (acetylcholinesterase reactivating oxime drug; PAM-A) by intravenous route.
Standard care+ 2.5 mg Salbutamol= Nebulized salbutamol (Ventolin respiratory solution) 2.5 mg stat and once only with standard care
Standard care+ 5 mg Salbutamol= Nebulized salbutamol (Ventolin respiratory solution) 5 mg stat and once only with standard care